Skip to content

comparison of effects of nasal route dexmedetomidine and intravenous infusion dexmedetomidine on blood pressure and heart rate during operation

Comparison of single dose intranasal dexmedetomidine v/s intravenous infusion for maintenance of perioperative haemodynamics- A Prospactive Randomized Placebo controled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017184
Enrollment
90
Registered
2019-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H669- Otitis media, unspecified

Interventions

Intervention1: Dexmedetomidine: Intranasal Dexmedetomidine 2microgm/kg Control Intervention1: Dexmedetomidine: Intravenous dexmedetomidine 1 microgm/kg for initial 10 mins then 0.5 microgm/kg infusion

Sponsors

Department of Anaesthesiology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA I and II Posted for tympanoplasty

Exclusion criteria

Exclusion criteria: Patients having CVS and Respiratory disease coagulation disorder patent on medication

Design outcomes

Primary

MeasureTime frame
Intraoperative haemodynamics stabilityTimepoint: intraoperative time

Secondary

MeasureTime frame
side effectsTimepoint: intraoperative period

Countries

India

Contacts

Public ContactYogendra Singhal

RNT Medical College

singhalyogi@yahoo.co.in9414850381

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026